While the ductal subtype accounts for 70% to 80% of all breast cancers and the lobular subtype accounts for just 10% to 15%, the lobular subtype is more common among peri- and postmenopausal women, is ...

I am a radiation oncologist and was recently referred a 71-year-old woman, diagnosed in October 2003 with a multifocal invasive ductal carcinoma (1.9 and 0.9 cm) -- grade 2, estrogen-receptor ...

Facing a breast cancer diagnosis can be an overwhelming experience, filled with uncertainty and fear, but knowledge is a ...

Waiting and seeing is not often the strategy employed when it comes to treating breast cancer, but a new clinical trial by the University of California, San Francisco, researchers are doing just that.

A total of 756 women with early stage invasive breast carcinoma or ductal carcinoma in situ underwent BCT including definitive breast irradiation during 1992 to 2001. At the time of initial diagnosis ...

Please provide your email address to receive an email when new articles are posted on . Women with a history of ductal carcinoma in situ reported confusion and concern about diagnosis and treatment of ...

Despite being the second most prevalent histologic subtype of invasive breast cancer in the U.S., invasive lobular carcinoma is often detected later and yields worse outcomes than invasive ductal ...

MSK created this program because we’re experts in treating this type of cancer. Lobular breast cancer is very different from invasive ductal carcinoma, the most common type of breast cancer. It’s ...

A recent study found that breast cancer–specific survival in patients with invasive lobular carcinoma was inferior compared to patients with invasive ductal carcinoma. A recent study found that breast ...